Changes to CredibleMeds Lists - Smartphone Apps
February 11, 2017 at 10:31 PM
The safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs. Therefore, we wnat to inform you of the following changes to the QTdrugs.org lists:
1. Addition of pilsicainide (on market in Japan) and prothipendyl (on European markets) to the Possible Risk List.
2. Addition of terodiline (Micturin and Mictrol) to the Known Risk (KR) List. This drug has been removed from the market in many countries because of TdP. Because it may still be available in some countries, we have added it to the KR list. Note that the brand Mictrol may contain a different drug (bethanechol) in some countries.
Also, we remind you of the availability of the newly released, free CredibleMeds Mobile Apps !
You can access the iPhone application in the iOS App Store by clicking here:
The Apps are synced to the CredibleMeds drugs lists and are therefore always an up-to-date resource for you to search for drugs of interest.
We hope you will find the Apps to be of value and we seek your feedback for ways they might be improved to better serve your needs.
We wish to recognize the support of the FDA's Safe Use Initiative, the Bert W. Martin Foundation, numerous donors and the technical expertise of Keith Symmonds, a talented programmer with Congenital Long QT Syndrome, that made these Apps possible.
Thank you for your support of CredibleMeds.org.